🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate two new GSK1265744 sodium salt tablet formulations...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-02
Trial ID
NCT02059031
Treatments Being Tested
The RELATIVITY study is a nationwide, multicenter, ambispective observation...
Status
Active Not Recruiting
Location
Hospital Universitario de Burgos
Start Date
2024-12-31
Trial ID
NCT07703748
The purpose of this study is to evaluate if offering long-acting injectable...
Status
Not Yet Recruiting
Location
Hôpital Hôtel Dieu
Start Date
2024-04-01
Trial ID
NCT06273943
The primary objective of this study is to evaluate uptake and retention of ...
Status
Terminated
Location
Orlando Immunology Center
Start Date
2023-06-21
Trial ID
NCT05755204
This study will establish the minimum safety, tolerability and acceptabilit...
Status
Completed
Location
University of Colorado Denver ATN CRS
Start Date
2020-02-19
Trial ID
NCT04692077
Treatments Being Tested
This Antiretroviral Therapy as Long Acting Suppression every 2 Months (ATLA...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2017-10-27
Trial ID
NCT03299049
The LATA trial will find out if taking a long-acting injectable form of HIV...
Status
Unknown
Location
Moi University
Start Date
2023-06-22
Trial ID
NCT05154747
Treatments Being Tested
This study is a Phase IIb, randomized, multicentre, parallel group, open-la...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-04-28
Trial ID
NCT02120352
Treatments Being Tested
This is a Phase I/II, multicenter, open-label, non-randomized study with fo...
Status
Withdrawn
Location
Site 4601, University of California, UC San Diego CRS- Mother-Child-Adolescent HIV Program
Start Date
2025-05-01
Trial ID
NCT06336434
Treatments Being Tested
This is a Phase I, single-center, open-label, fixed-sequence, 2-period cros...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-06-06
Trial ID
NCT03149848
Treatments Being Tested